health

A remarkable development in the treatment of a deadly disease has earned a national honor for Texas A&M University.

Researchers from the Texas A&M Center for Worker Health say Labor Day isn’t just a break, it’s a chance to reset and prepare for the rest of the year at work

Texas A&M research institute releases final installment of study highlighting the pandemic's neurological impact and raising concerns about Chinese military research on coronaviruses.

School of Public Health research could inform new strategies to increase preparedness nationwide.

America is rapidly aging as the second largest generation, Baby Boomers, will be at least 65 by 2029. Texas A&M University researchers are developing new ways to help older people tackle challenges that come with aging.

Major new film is sponsored by REI and produced by Robert Redford’s environmental philanthropy.

With over $1.2 million in seed funding, the Dementia & Alzheimer’s Research Initiative (DARI) unites researchers across disciplines to drive breakthroughs in prevention, diagnosis and care.

A Texas A&M University expert explains the health benefits of the supplement.

Developed by biopharmaceutical company Ultragenyx, GTX-102 is the first clinically developed drug targeting the genetic causes of Angelman syndrome rather than symptoms.

A new platform mimics various blood vessel structures, enabling more accurate models of vascular disease and patient-specific research.